Cite

HARVARD Citation

    Broutin, S. et al. (n.d.). SERUM 2‐HYDROXYGLUTARATE, A PREDICTIVE BIOMARKER OF THE PRESENCE OF IDH2 MUTATIONS IN AITL PATIENTS. Hematological oncology. p. 392. [Online]. 
  
Back to record